238 related articles for article (PubMed ID: 32051331)
1. Second tier non-invasive prenatal testing in a regional prenatal diagnosis service unit: a retrospective analysis and literature review.
Ng VKS; Chan AL; Lau WL; Leung WC
Hong Kong Med J; 2020 Feb; 26(1):10-18. PubMed ID: 32051331
[TBL] [Abstract][Full Text] [Related]
2. Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units.
Chitty LS; Wright D; Hill M; Verhoef TI; Daley R; Lewis C; Mason S; McKay F; Jenkins L; Howarth A; Cameron L; McEwan A; Fisher J; Kroese M; Morris S
BMJ; 2016 Jul; 354():i3426. PubMed ID: 27378786
[TBL] [Abstract][Full Text] [Related]
3. Women's preference for non-invasive prenatal DNA testing versus chromosomal microarray after screening for Down syndrome: a prospective study.
Cheng Y; Leung WC; Leung TY; Choy KW; Chiu R; Lo TK; Kwok KY; Sahota DS
BJOG; 2018 Mar; 125(4):451-459. PubMed ID: 29125674
[TBL] [Abstract][Full Text] [Related]
4. Knowledge and future preference of Chinese women in a major public hospital in Hong Kong after undergoing non-invasive prenatal testing for positive aneuploidy screening: a questionnaire survey.
Kou KO; Poon CF; Tse WC; Mak SL; Leung KY
BMC Pregnancy Childbirth; 2015 Sep; 15():199. PubMed ID: 26330276
[TBL] [Abstract][Full Text] [Related]
5. Effect of non-invasive prenatal testing as a contingent approach on the indications for invasive prenatal diagnosis and prenatal detection rate of Down's syndrome.
Kou KO; Poon CF; Kwok SL; Chan KY; Tang MH; Kan AS; Leung KY
Hong Kong Med J; 2016 Jun; 22(3):223-30. PubMed ID: 27149976
[TBL] [Abstract][Full Text] [Related]
6. Service provision of non-invasive prenatal testing for Down syndrome in public and private healthcare sectors: a qualitative study with obstetric providers.
Ngan OMY; Yi H; Ahmed S
BMC Health Serv Res; 2018 Sep; 18(1):731. PubMed ID: 30241520
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol.
Hill M; Wright D; Daley R; Lewis C; McKay F; Mason S; Lench N; Howarth A; Boustred C; Lo K; Plagnol V; Spencer K; Fisher J; Kroese M; Morris S; Chitty LS
BMC Pregnancy Childbirth; 2014 Jul; 14():229. PubMed ID: 25027965
[TBL] [Abstract][Full Text] [Related]
8. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
9. Obstetric professionals' perceptions of non-invasive prenatal testing for Down syndrome: clinical usefulness compared with existing tests and ethical implications.
Ngan OMY; Yi H; Wong SYS; Sahota D; Ahmed S
BMC Pregnancy Childbirth; 2017 Sep; 17(1):285. PubMed ID: 28870159
[TBL] [Abstract][Full Text] [Related]
10. TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.
van der Meij KRM; Sistermans EA; Macville MVE; Stevens SJC; Bax CJ; Bekker MN; Bilardo CM; Boon EMJ; Boter M; Diderich KEM; de Die-Smulders CEM; Duin LK; Faas BHW; Feenstra I; Haak MC; Hoffer MJV; den Hollander NS; Hollink IHIM; Jehee FS; Knapen MFCM; Kooper AJA; van Langen IM; Lichtenbelt KD; Linskens IH; van Maarle MC; Oepkes D; Pieters MJ; Schuring-Blom GH; Sikkel E; Sikkema-Raddatz B; Smeets DFCM; Srebniak MI; Suijkerbuijk RF; Tan-Sindhunata GM; van der Ven AJEM; van Zelderen-Bhola SL; Henneman L; Galjaard RH; Van Opstal D; Weiss MM;
Am J Hum Genet; 2019 Dec; 105(6):1091-1101. PubMed ID: 31708118
[TBL] [Abstract][Full Text] [Related]
11. Uptake of fetal aneuploidy screening after the introduction of the non-invasive prenatal test: A national population-based register study.
van der Meij KRM; de Groot-van Mooren M; Carbo EWS; Pieters MJ; Rodenburg W; Sistermans EA; Cornel MC; Henneman L;
Acta Obstet Gynecol Scand; 2021 Jul; 100(7):1265-1272. PubMed ID: 33465829
[TBL] [Abstract][Full Text] [Related]
12. Motivations for undertaking DNA sequencing-based non-invasive prenatal testing for fetal aneuploidy: a qualitative study with early adopter patients in Hong Kong.
Yi H; Hallowell N; Griffiths S; Yeung Leung T
PLoS One; 2013; 8(11):e81794. PubMed ID: 24312358
[TBL] [Abstract][Full Text] [Related]
13. Women's Experiences and Preferences for Service Delivery of Non-Invasive Prenatal Testing for Aneuploidy in a Public Health Setting: A Mixed Methods Study.
Lewis C; Hill M; Chitty LS
PLoS One; 2016; 11(4):e0153147. PubMed ID: 27045195
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of prenatal screening and diagnostic strategies for Down syndrome: A microsimulation modeling analysis.
Zhang W; Mohammadi T; Sou J; Anis AH
PLoS One; 2019; 14(12):e0225281. PubMed ID: 31800591
[TBL] [Abstract][Full Text] [Related]
15. Decision-making for non-invasive prenatal testing for Down syndrome: Hong Kong Chinese women's preferences for individual vs relational autonomy.
Lau JY; Yi H; Ahmed S
Clin Genet; 2016 May; 89(5):550-6. PubMed ID: 26864268
[TBL] [Abstract][Full Text] [Related]
16. Uptake of non-invasive prenatal testing in Chinese women: money matters.
Han J; Zhen L; Pan M; Yang X; Ou YM; Liao C; Li DZ
Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():100-102. PubMed ID: 26512434
[TBL] [Abstract][Full Text] [Related]
17. Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening.
Chetty S; Garabedian MJ; Norton ME
Prenat Diagn; 2013 Jun; 33(6):542-6. PubMed ID: 23592525
[TBL] [Abstract][Full Text] [Related]
18. The potential impact of NIPT as a second-tier screen on the outcomes of high-risk pregnancies with rare chromosomal abnormalities.
Maxwell S; Dickinson JE; Murch A; O'Leary P
Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):420-6. PubMed ID: 26286670
[TBL] [Abstract][Full Text] [Related]
19. Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies.
O'Leary P; Maxwell S; Murch A; Hendrie D
Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):425-33. PubMed ID: 24090461
[TBL] [Abstract][Full Text] [Related]
20. Uptake of non-invasive prenatal testing (NIPT) and impact on invasive procedures in a tertiary referral center.
Manegold-Brauer G; Berg C; Flöck A; Rüland A; Gembruch U; Geipel A
Arch Gynecol Obstet; 2015 Sep; 292(3):543-8. PubMed ID: 25716672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
